Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03177265 · ClinicalTrials.gov registry record · NA
Text Messaging to Engage and Retain Veterans in Smoking Cessation Counseling
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 432
- Enrollment target
NCT03177265: Completed NA study, sponsored by VA Office of Research and Development.
NCT03177265 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 432 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03177265, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 432 participants
- Enrollment target
Study Summary
Tobacco-related diseases account for a significant portion of all VA healthcare costs and are a detriment to the health and quality of life of our Veterans. Despite progress in instituting tobacco screenings and treatment referral, most Veterans still do not receive the most effective strategy to help them quit smoking - pharmacotherapy combined with behavioral coaching. This study builds on findings from population health and mobile interventions to help more Veterans receive evidence-based tobacco treatment. The investigators propose to test the effect of two types of text messaging in combination with telephone cessation counseling: 1) pre-counseling text messages to increase enrollment in counseling, and 2) ongoing texts for those who start counseling that provide appointment reminders and support between sessions to increase adherence to counseling. This study supports multiple goals of the VA's Blueprint for Excellence. Results will directly inform decision-making and population-based care models for tobacco treatment.
Primary Outcome
Tobacco cessation will be verified via oral swab cotinine.
Interventions
- BEHAVIORAL Telephone Counseling
- BEHAVIORAL Text messaging prior to first counseling call
- BEHAVIORAL Text-to-Enhance
- BEHAVIORAL Mail Notice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 432 participants |
| Start Date | 2018-11-08 |
| Est. Completion | 2021-11-01 |
| Phase | NA |
What the finished NCT03177265 record still lists
NCT03177265 is an interventional study that assigns participants to a tested intervention. The registered 432 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower).
The record links to 0 conditions, and to 4 interventions - of which Telephone Counseling is the first listed.
NCT03177265 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03177265 about?
NCT03177265 is a clinical study titled "Text Messaging to Engage and Retain Veterans in Smoking Cessation Counseling". Tobacco-related diseases account for a significant portion of all VA healthcare costs and are a detriment to the health and quality of life of our Veterans. Despite progress in instituting tobacco screenings and treatment referral, most Veterans still do not receive the most effective strategy to he...
What is the current status of trial NCT03177265?
This trial is currently completed. It is a NA study. The enrollment target is 432 participants. The study started on 2018-11-08. Estimated completion is 2021-11-01.
What interventions are being tested in trial NCT03177265?
The interventions under investigation include: Telephone Counseling (BEHAVIORAL), Text messaging prior to first counseling call (BEHAVIORAL), Text-to-Enhance (BEHAVIORAL), Mail Notice (BEHAVIORAL).
Who is sponsoring clinical trial NCT03177265?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03177265's enrollment target sits among peer trials
432 235th of 2000 higher than 1,766 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05271240 · 432 participants · Phase 3
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
- NCT05365815 · 432 participants · NA
Melanated Group Midwifery Care (MGMC)
- NCT05499507 · 432 participants · NA
The Path to Optimal Black Maternal Heart Health: Comparing Two CVD Risk Reduction Interventions (Change of HEART)
- NCT05806164 · 432 participants · Phase 4
Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI